169 related articles for article (PubMed ID: 30088919)
1. Tackling Pseudomonas aeruginosa Virulence by a Hydroxamic Acid-Based LasB Inhibitor.
Kany AM; Sikandar A; Yahiaoui S; Haupenthal J; Walter I; Empting M; Köhnke J; Hartmann RW
ACS Chem Biol; 2018 Sep; 13(9):2449-2455. PubMed ID: 30088919
[TBL] [Abstract][Full Text] [Related]
2. Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection.
Cathcart GR; Quinn D; Greer B; Harriott P; Lynas JF; Gilmore BF; Walker B
Antimicrob Agents Chemother; 2011 Jun; 55(6):2670-8. PubMed ID: 21444693
[TBL] [Abstract][Full Text] [Related]
3. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y
PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
[TBL] [Abstract][Full Text] [Related]
4. Binding Mode Characterization and Early in Vivo Evaluation of Fragment-Like Thiols as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa.
Kany AM; Sikandar A; Haupenthal J; Yahiaoui S; Maurer CK; Proschak E; Köhnke J; Hartmann RW
ACS Infect Dis; 2018 Jun; 4(6):988-997. PubMed ID: 29485268
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the binding specificity of two bacterial metalloproteases, LasB of Pseudomonas aeruginosa and ZapA of Proteus mirabilis, using N-alpha mercaptoamide template-based inhibitor analogues.
Carson L; Cathcart GR; Ceri H; Walker B; Gilmore BF
Biochem Biophys Res Commun; 2012 Jun; 422(2):316-20. PubMed ID: 22575503
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
Li Y; Huang J; Li L; Liu L
Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
[TBL] [Abstract][Full Text] [Related]
7. A drug-repositioning screening identifies pentetic acid as a potential therapeutic agent for suppressing the elastase-mediated virulence of Pseudomonas aeruginosa.
Gi M; Jeong J; Lee K; Lee KM; Toyofuku M; Yong DE; Yoon SS; Choi JY
Antimicrob Agents Chemother; 2014 Dec; 58(12):7205-14. PubMed ID: 25246397
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa elastase (LasB) as a therapeutic target.
Everett MJ; Davies DT
Drug Discov Today; 2021 Sep; 26(9):2108-2123. PubMed ID: 33676022
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of quorum sensing regulated virulence and biofilm development in Pseudomonas aeruginosa PAO1 by Diaporthe phaseolorum SSP12.
Pattnaik SS; Ranganathan S; Ampasala DR; Syed A; Ameen F; Busi S
Microb Pathog; 2018 May; 118():177-189. PubMed ID: 29571725
[TBL] [Abstract][Full Text] [Related]
10. Application of Dual Inhibition Concept within Looped Autoregulatory Systems toward Antivirulence Agents against Pseudomonas aeruginosa Infections.
Thomann A; de Mello Martins AG; Brengel C; Empting M; Hartmann RW
ACS Chem Biol; 2016 May; 11(5):1279-86. PubMed ID: 26882081
[TBL] [Abstract][Full Text] [Related]
11.
Konstantinović J; Yahiaoui S; Alhayek A; Haupenthal J; Schönauer E; Andreas A; Kany AM; Müller R; Koehnke J; Berger FK; Bischoff M; Hartmann RW; Brandstetter H; Hirsch AKH
J Med Chem; 2020 Aug; 63(15):8359-8368. PubMed ID: 32470298
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Putative Virulence Factors of
Rigane E; Dutoit R; Matthijs S; Brandt N; Flahaut S; Belghith KS
Biomed Res Int; 2020; 2020():6047528. PubMed ID: 32775429
[No Abstract] [Full Text] [Related]
13. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability-enhanced Resveramax™ modulates quorum sensing and inhibits biofilm formation in Pseudomonas aeruginosa PAO1.
Vasavi HS; Sudeep HV; Lingaraju HB; Shyam Prasad K
Microb Pathog; 2017 Mar; 104():64-71. PubMed ID: 28065820
[TBL] [Abstract][Full Text] [Related]
15. The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo.
Uusitalo P; Hägglund U; Rhöös E; Scherman Norberg H; Elofsson M; Sundin C
J Antibiot (Tokyo); 2017 Aug; 70(9):937-943. PubMed ID: 28588224
[TBL] [Abstract][Full Text] [Related]
16. 3,6-Di(pyridin-2-yl)-1,2,4,5-tetrazine (pytz)-capped silver nanoparticles (TzAgNPs) inhibit biofilm formation of Pseudomonas aeruginosa: a potential approach toward breaking the wall of biofilm through reactive oxygen species (ROS) generation.
Chakraborty P; Joardar S; Ray S; Biswas P; Maiti D; Tribedi P
Folia Microbiol (Praha); 2018 Nov; 63(6):763-772. PubMed ID: 29855854
[TBL] [Abstract][Full Text] [Related]
17. A Dual-Specificity Inhibitor Targets Polyphosphate Kinase 1 and 2 Enzymes To Attenuate Virulence of Pseudomonas aeruginosa.
Neville N; Roberge N; Ji X; Stephen P; Lu JL; Jia Z
mBio; 2021 Jun; 12(3):e0059221. PubMed ID: 34126765
[TBL] [Abstract][Full Text] [Related]
18. Disarming Pseudomonas aeruginosa virulence factor LasB by leveraging a Caenorhabditis elegans infection model.
Zhu J; Cai X; Harris TL; Gooyit M; Wood M; Lardy M; Janda KD
Chem Biol; 2015 Apr; 22(4):483-491. PubMed ID: 25892201
[TBL] [Abstract][Full Text] [Related]
19. Scaffold of Selenium Nanovectors and Honey Phytochemicals for Inhibition of
Prateeksha ; Singh BR; Shoeb M; Sharma S; Naqvi AH; Gupta VK; Singh BN
Front Cell Infect Microbiol; 2017; 7():93. PubMed ID: 28386534
[TBL] [Abstract][Full Text] [Related]
20. Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections.
Wagner S; Sommer R; Hinsberger S; Lu C; Hartmann RW; Empting M; Titz A
J Med Chem; 2016 Jul; 59(13):5929-69. PubMed ID: 26804741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
